Adrian Mander
Cardiff University
H-index: 39
Europe-United Kingdom
Top articles of Adrian Mander
Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes
Diabetes/Metabolism Research and Reviews
2024/2
Handling Incomplete or Late-Onset Toxicities in Early-Phase Dose-Finding Clinical Trials: Current Practice and Future Prospects
2024/1
Gene expression signature predicts rate of type 1 diabetes progression
EBioMedicine
2023/6/1
Gianluca Mazzoni
H-Index: 11
David Dunger
H-Index: 69
Mark Peakman
H-Index: 36
Søren Brunak
H-Index: 77
Mikael Knip
H-Index: 63
Chris Wallace
H-Index: 45
Mark Evans
H-Index: 5
Sarah Richardson
H-Index: 17
Adrian Mander
H-Index: 26
Jorma Toppari
H-Index: 58
Michele Solimena
H-Index: 32
Stefano Cianfarani
H-Index: 24
Lars Krogvold
H-Index: 19
Tadej Battelino
H-Index: 37
Bernard Thorens
H-Index: 54
Allison Goldfine
H-Index: 48
Anne Smith
H-Index: 5
Simon Heller
H-Index: 5
Thomas Meissner
H-Index: 7
Bart Eeckhout
H-Index: 7
Development process of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE (DosE FIndiNg Extensions) study
2023/4
SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions) study protocol
BMJ open
2023/3/1
79MO Developing international consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: The DEFINE (DosE FIndiNg Extensions) study
ESMO Open
2023/2/1
Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL‐286, a novel retinoic acid receptor‐β agonist for treatment of spinal cord injury, in male …
British Journal of Clinical Pharmacology
2023/12
Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT Dose-finding Extension (CONSORT-DEFINE) guidance
bmj
2023/10/20
Enhancing quality and impact of early phase dose-finding clinical trial protocols: SPIRIT Dose-finding Extension (SPIRIT-DEFINE) guidance
bmj
2023/10/20
TACTS: Stata module to provide a clinical trial simulator
2022/4/29
Adrian Mander
H-Index: 26
The need for reporting guidelines for early phase dose-finding trials: dose-finding consort extension
Nature Medicine
2022/1
In the article cited above, the affiliation for author Marjana Marinac appeared incorrectly due to a journal composition error; Dr. Marinac’s correct affiliation is JDRF …
Diabetes Care
2022/12
Erratum. Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes. Diabetes Care 2022 …
Diabetes Care
2022/12
Optimised point estimators for multi-stage single-arm phase II oncology trials
Journal of Biopharmaceutical Statistics
2022/2/24
Innovative designs and logistical considerations for expedited clinical development of combination disease-modifying treatments for type 1 diabetes
2022/10/1
Subgroup analyses in randomized controlled trials frequently categorized continuous subgroup information
2022/10/1
A stochastically curtailed single‐arm phase II trial design for binary outcomes
Journal of Biopharmaceutical Statistics
2022/1/25
Simulating clinical trial designs
2022/6/25
Adrian Mander
H-Index: 26
INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes
2022/5/18
David Dunger
H-Index: 69
Adrian Mander
H-Index: 26
MVTNORM: Stata module to work with the multivariate normal and multivariate t distributions, with and without variable truncation
2021/12/24
Adrian Mander
H-Index: 26
Co-Authors
